Rankings
▼
Calendar
GERN Q3 2025 Earnings — Geron Corporation Revenue & Financial Results | Market Cap Arena
GERN
Geron Corporation
$1B
Q3 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$47M
+67.1% YoY
Gross Profit
$25M
53.2% margin
Operating Income
-$14M
-29.4% margin
Net Income
-$18M
-39.0% margin
EPS (Diluted)
$-0.03
QoQ Revenue Growth
-3.7%
Cash Flow
Operating Cash Flow
-$14M
Free Cash Flow
-$13M
Stock-Based Comp.
$7M
Balance Sheet
Total Assets
$567M
Total Liabilities
$319M
Stockholders' Equity
$249M
Cash & Equivalents
$78M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$47M
$28M
+67.1%
Gross Profit
$25M
$28M
-9.7%
Operating Income
-$14M
-$28M
+50.8%
Net Income
-$18M
-$26M
+30.3%
Revenue Segments
Revenues Before Adjustments
$60M
56%
Product
$47M
44%
← FY 2025
All Quarters
Q4 2025 →